Q99PF4 (CAD23_MOUSE) Mus musculus (Mouse)

Cadherin-23 UniProtKBInterProSTRINGInteractive Modelling

3354 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6)

Available Structures

27 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2 FORM I Heteromer
Q99PJ1;
24-228
CA;MES;CL;K;GOL;
Assess
CRYSTAL STRUCTURE OF DEAFNESS ASSOCIATED MUTANT MOUSE CADHERIN-23 EC1- 2D124G AND PROTOCADHERIN-15 … Heteromer
Q99PJ1;
24-228
CA;MES;CL;K;
Assess
CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2, FORM I 2.2A. Heteromer
Q99PJ1;
24-228
CA;MES;PG4;CL;GOL;K;
Assess
CRYSTAL STRUCTURE OF DEAFNESS ASSOCIATED MUTANT MOUSE CADHERIN-23 EC1- 2S70P AND PROTOCADHERIN-15 E… Heteromer
Q99PJ1;
24-228
CA;MES;K;
Assess
CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 AND PROTOCADHERIN-15 EC1- 2 FORM II Heteromer
Q99PJ1;
24-228
CA;
Assess
Crystal structure of mouse Cadherin-23 EC1-2 and Protocadherin-15 EC1-2 splice variant Heteromer
Q99PJ1;
24-227
CA;CL;
Assess
Crystal Structure of Human Protocadherin-15 EC1-3 G16D N369D Q370N and Mouse Cadherin-23 EC1-2 T15E Heteromer
Q96QU1;
25-221
18×CA;
Assess
Crystal Structure of Mouse Cadherin-23 EC19-21 S2064Pmonomer1952-2286
CA;
Assess
Crystal Structure of Mouse Cadherin-23 EC19-21 WTmonomer1952-2286
CA;
Assess
Crystal Structure of Mouse Cadherin-23 EC19-21 with non-syndromic deafness (DFNB12) associated muta…monomer1955-2288
CA;K;
Assess
Crystal Structure of Mouse Cadherin-23 EC19-21 (S2087P) with non-syndromic deafness (DFNB12) associ…monomer1957-2285
CA;
Assess
Crystal Structure of Mouse Cadherin-23 EC22-24monomer2288-2604
CL;CA;GSH;
Assess
Crystal Structure of Mouse Cadherin-23 EC13-15monomer1311-1624
CA;ACT;
Assess
Crystal Structure of Mouse Cadherin-23 EC25-26monomer2604-2841
CA;K;CL;
Assess
Crystal Structure of Mouse Cadherin-23 EC7+8monomer668-884
NA;CA;
Assess
Crystal Structure of Mouse Cadherin-23 EC18-19monomer1847-2062
CA;CL;
Assess
Crystal Structure of Mouse Cadherin-23 EC17-18monomer1739-1954
CA;K;MPD;
Assess
Crystal Structure of Mouse Cadherin-23 EC8-9monomer770-985
CA;NA;
Assess
Crystal Structure of Mouse Cadherin-23 EC16-17monomer1631-1845
CA;
Assess
Crystal Structure of Mouse Cadherin-23 EC24-25monomer2504-2715
CA;
Assess
Structure of the N-terminus of Cadherin 23monomer24-233
CA; 22×EDO;
Assess
Crystal Structure of Mouse Cadherin-23 EC12-13 with Engineered Mutation S1339Dmonomer1202-1410
CA;NA;
Assess
CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2monomer24-228
CA;NA;CL;GOL;
Assess
CRYSTAL STRUCTURE OF MOUSE CADHERIN-23 EC1-2 (ALL CATION BINDING SITES OCCUPIED BY CALCIUM)monomer24-228
CA;K;CL;GOL;
Assess
CRYSTAL STRUCTURE OF NONSYNDROMIC DEAFNESS (DFNB12) ASSOCIATED MUTANT D124G OF MOUSE CADHERIN-23 EC…monomer24-228
CA;NA;CL;
Assess
Crystal Structure of Mouse Cadherin-23 EC9monomer883-987
CA;
Assess
Crystal structure of mouse cadherin-23 EC1monomer24-124
CA;
Assess

14 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6vg4.1.Amonomer0.58999-1626
CA;29.32
Assess
6vg4.1.Amonomer0.571166-1721
CA;34.88
Assess
6vg4.1.Amonomer0.57894-1519
CA;27.64
Assess
6vg4.1.Amonomer0.57565-1200
CA;29.17
Assess
6vg1.1.Amonomer0.56894-1518
CA;29.30
Assess
6vg1.1.Amonomer0.56565-1199
CA;27.54
Assess
6vg4.1.Amonomer0.541513-2061
CA;33.90
Assess
6vg1.1.Bmonomer0.541135-1721
CA;33.10
Assess
6e6b.1.Amonomer0.53675-1307
CA;27.18
Assess
6vg4.1.Amonomer0.531837-2394
CA;33.33
Assess
6e6b.1.Amonomer0.53782-1412
CA;25.81
Assess
6vg1.1.Amonomer0.511040-1620
CA;32.85
Assess
6e6b.1.Amonomer0.51464-1096
CA;30.02
Assess
1q55.1.Amonomer0.501001-1525
CA;23.06
Assess

40 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26vg4.1.Amonomer0.59999-1626
CA;29.32
Assess
Isoform 26vg4.1.Amonomer0.58894-1519
CA;27.64
Assess
Isoform 26vg4.1.Amonomer0.571166-1721
CA;34.88
Assess
Isoform 26vg1.1.Amonomer0.57675-1304
CA;25.82
Assess
Isoform 26vg4.1.Amonomer0.57565-1200
CA;29.17
Assess
Isoform 26vg1.1.Amonomer0.57894-1518
CA;29.30
Assess
Isoform 26vg4.1.Amonomer0.56675-1305
CA;26.47
Assess
Isoform 26vg1.1.Amonomer0.56565-1199
CA;27.54
Assess
Isoform 26vg1.1.Amonomer0.561135-1721
CA;33.10
Assess
Isoform 26vg4.1.Amonomer0.541513-2061
CA;33.90
Assess
Isoform 26e6b.1.Amonomer0.53782-1412
CA;25.81
Assess
Isoform 26vg4.1.Amonomer0.521837-2394
CA;33.33
Assess
Isoform 26e6b.1.Amonomer0.51464-1096
CA;30.02
Assess
Isoform 26vg1.1.Bmonomer0.511040-1620
CA;32.85
Assess
Isoform 21q55.1.Amonomer0.501001-1525
CA;23.06
Assess
Isoform 46vg4.1.Amonomer0.58166-712
CA;26.72
Assess
Isoform 46e6b.1.Ahomo-2-mer0.5660-714
CA;26.39
Assess
Isoform 43q2w.1.Bhomo-2-mer0.5561-597
CA;26.95
Assess
Isoform 47a7d.1.Hmonomer0.54168-712
22.18
Assess
Isoform 43q2w.1.Bhomo-2-mer0.54167-711
CA;24.95
Assess
Isoform 47a7d.1.Amonomer0.5359-607
23.18
Assess
Isoform 46c13.1.Ahomo-2-mer0.53266-813
22.80
Assess
Isoform 47a7d.1.Dmonomer0.5259-607
23.18
Assess
Isoform 45erd.1.Ahomo-2-mer0.52162-712
23.35
Assess
Isoform 47a7d.1.Emonomer0.52162-712
23.31
Assess
Isoform 47a7d.1.Amonomer0.51162-712
23.31
Assess
Isoform 47a7d.1.Dmonomer0.51162-712
23.31
Assess
Isoform 56vg4.1.Amonomer0.57165-712
CA;26.67
Assess
Isoform 56e6b.1.Ahomo-2-mer0.5660-714
CA;26.39
Assess
Isoform 53q2w.1.Bhomo-2-mer0.5561-597
CA;26.95
Assess
Isoform 57a7d.1.Hmonomer0.53168-713
22.13
Assess
Isoform 53q2w.1.Bhomo-2-mer0.53167-711
CA;24.90
Assess
Isoform 57a7d.1.Amonomer0.5359-607
23.18
Assess
Isoform 56c13.1.Ahomo-2-mer0.53266-813
22.80
Assess
Isoform 55erd.1.Ahomo-2-mer0.52162-712
23.35
Assess
Isoform 57a7d.1.Dmonomer0.5259-607
23.18
Assess
Isoform 57a7d.1.Emonomer0.52162-712
23.31
Assess
Isoform 57a7d.1.Amonomer0.51162-712
23.31
Assess
Isoform 57a7d.1.Dmonomer0.51162-712
23.31
Assess
Isoform 56vg1.1.Ahomo-2-mer0.50146-665
CA;32.79
Assess